Fonte: Final Program. Nome do evento: Annual Meeting and Exposition of the Controlled Release Society. Unidades: IF, FCFRP
Assunto: FARMACOTÉCNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Luciana Biagini et al. Aqueous nanodispersion of reversed hexagonal phase containing cyclosporin A: obtainment, characterization and In vitro/In vivo skin delivery. 2004, Anais.. Mineápolis: Controlled Release Society, 2004. . Acesso em: 24 jul. 2024.APA
Lopes, L. B., Ferreira, D. A., Fantini, M. C. de A., Santana, M. H. A., & Bentley, M. V. L. B. (2004). Aqueous nanodispersion of reversed hexagonal phase containing cyclosporin A: obtainment, characterization and In vitro/In vivo skin delivery. In Final Program. Mineápolis: Controlled Release Society.NLM
Lopes LB, Ferreira DA, Fantini MC de A, Santana MHA, Bentley MVLB. Aqueous nanodispersion of reversed hexagonal phase containing cyclosporin A: obtainment, characterization and In vitro/In vivo skin delivery. Final Program. 2004 ;[citado 2024 jul. 24 ]Vancouver
Lopes LB, Ferreira DA, Fantini MC de A, Santana MHA, Bentley MVLB. Aqueous nanodispersion of reversed hexagonal phase containing cyclosporin A: obtainment, characterization and In vitro/In vivo skin delivery. Final Program. 2004 ;[citado 2024 jul. 24 ]